Gefitinib plus Fuzheng Kang'ai Formula (扶正抗癌方) in patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutation: a …
X Yang, X Chai, W Wu, S Long, H Deng, Z Pan… - Chinese journal of …, 2018 - Springer
… treatment with gefitinib plus FZKA conferred longer PFS and MST than treatment with gefitinib
alone in patients … role in assisting gefitinib to prolong survival of the patients with advanced …
alone in patients … role in assisting gefitinib to prolong survival of the patients with advanced …
[PDF][PDF] 厄洛替尼治疗晚期复治非小细胞肺癌45 例的临床观察
唐俊舫， 朱允中， 刘喆， 武玮， 刘赞， 史鹤玲… - 中国肺癌 …, 2009 - scholar.archive.org
… the one-year survival rate of patients with advanced non-small cell lung cancer. The aim of
this … reaction of agent erlotinib in advanced and previously treated non-small-cell lung cancer. …
this … reaction of agent erlotinib in advanced and previously treated non-small-cell lung cancer. …
[HTML][HTML] 晚期EGFR 突变型非小细胞肺癌患者接受吉非替尼或厄洛替尼治疗的成本效益分析
马宇翔， 黄岩， 赵洪云， 刘俊玲， 陈丽昆… - … Journal of Lung …, 2013 - ncbi.nlm.nih.gov
… For EGFR mutant advanced NSCLC patients, equal efficacy and survival … in patients with
gefitinib and erlotinib.The adverse reaction was milder in gefitinib group than that of erlotinib …
gefitinib and erlotinib.The adverse reaction was milder in gefitinib group than that of erlotinib …
表皮生长因子受体酪氨酸激酶抑制剂治疗肺腺鳞癌患者的疗效及影响因素
周生余， 胡兴胜， 李峻岭， 王燕… - Chinese Journal of …, 2018 - search.ebscohost.com
… Methods From August 2007 to July 2017, 40 patients who were pathologically diagnosed
as lung adenosquamous carcinoma in our hospital and received EGFR TKIs treatment were …
as lung adenosquamous carcinoma in our hospital and received EGFR TKIs treatment were …
[HTML][HTML] 厄洛替尼治疗34 例肺鳞癌患者的疗效观察
程芳， 王静， 陈洁， 邢镨元， 李峻岭 - Chinese Journal of Lung …, 2016 - ncbi.nlm.nih.gov
… of this study was to observe the effect of erlotinib in patients with squamous cell lung cancer.
… The effects of erlotinib on the advanced non-small cell lung cancer patients. Zhongguo Yi …
… The effects of erlotinib on the advanced non-small cell lung cancer patients. Zhongguo Yi …
[HTML][HTML] 晚期EGFR 阳性NSCLC 患者PD-L1 表达特点及其与EGFR-TKIs 治疗疗效关系的真实世界研究
C Ran, GAO Xiang, XU Fudong, S ZHANG… - … Journal of Lung …, 2023 - ncbi.nlm.nih.gov
… The factors affecting the therapeutic effect of EGFR-TKIs in 141 patients with EGFR sensitive
mutations were also explored. Results The PD-L1 expression of the included patients was …
mutations were also explored. Results The PD-L1 expression of the included patients was …
[HTML][HTML] EGFR-TKI 治疗EGFR 敏感突变的晚期肺鳞癌的疗效分析
刘咏梅， 赵倩， 唐源， 张衍， 李艳莹， 王永生， 卢铀 - 肿瘤防治研究, 2015 - zlfzyj.com
… investigate the efficacy of epidermal … advanced squamous cell lung carcinoma patients
with sensitive EGFR mutations. Methods We retrospectively analyzed 20 patients with advanced …
with sensitive EGFR mutations. Methods We retrospectively analyzed 20 patients with advanced …
奥希替尼一线治疗EGFR突变晚期非小细胞肺癌患者的疗效分析
王千毓， 李祥梦， 杨衿记 - 循证医学, 2021 - jebm.cn
… the clinical efficacy of first⁃line osimertinib in the treatment of advanced epidermal growth …
cell lung cancer(NSCLC)patients. Methods Thirty⁃five EGFR⁃mutated patients with advanced …
cell lung cancer(NSCLC)patients. Methods Thirty⁃five EGFR⁃mutated patients with advanced …
[PDF][PDF] 沙利度胺联合吉非替尼靶向治疗非小细胞肺癌的临床效果观察
王宏， 夏永寿， 加静， 张燕… - Progress in Modern …, 2018 - biomed.cnjournals.com
… of second line treatment for non small cell lung cancer (NSCLC)[J]. Lung Cancer, 2016, 91(1):
… controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR …
… controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR …
表皮生长因子受体敏感突变阳性非腺癌非小细胞肺癌的精准内科治疗.
王哲海， 宋心宇 - Chinese Journal of Oncology/Zhonghua …, 2017 - search.ebscohost.com
… efficacy of TKIs treatment for EGFR⁃mutated non⁃adenocarcinomas. The EGFR mutation
rate and efficacy of TKIs treatment in adenosquamous … or large cell lung carcinoma. It may be …
rate and efficacy of TKIs treatment in adenosquamous … or large cell lung carcinoma. It may be …